The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients
Clicks: 288
ID: 270447
1998
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
288 views
20 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #14 of 16 articles by views in the journal of infection
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Diarrhoea is a common side effect of antibiotic therapy, especially in the elderly. Saccharomyces boulardii is a non-pathogenic yeast which has been demonstrated to reduce the frequency of diarrhoea in patients due to a variety of causes. We set out to assess its role in preventing antibiotic-relate …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (47 words).
Try re-searching for a better abstract.
| Reference Key |
sj1998thethe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Lewis SJ;Potts LF;Barry RE;; |
| Journal | the journal of infection |
| Year | 1998 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
female
male
aged
80 and over
Clinical Trial
Randomized Controlled Trial
anti-bacterial agents / therapeutic use
diarrhea / prevention & control*
feces / microbiology
diarrhea / etiology
enterotoxins / analysis
anti-bacterial agents / adverse effects*
probiotics / therapeutic use*
pmid:9570649
doi:10.1016/s0163-4453(98)80008-x
s j lewis
l f potts
r e barry
clostridioides difficile / isolation & purification
saccharomyces*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.